{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04145",
    "Peptide Name": "Ctry2459-H2 analog (synthetic AMPs, Phe-rich; Leu-rich; UCLL1)",
    "Source": "amino acid substitution, scorpion, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FLGFLHHLF",
    "Sequence Length": 9,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Antiviral"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 3,
    "Boman Index": -1.7,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "67%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is most similar (77.78%) toCtry2459 WTL=F: 33%; H: 22%.Activity: inhibit hepatitis C virus (HCV) infection (EC50 1.08 ug/ml).Toxicity: Huh7.5.1 cells (LC50 >500 ug/ml).",
    "Author": "Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z.2013",
    "Reference": "Biomaterials. 2013 Apr;34(13):3511-22. doi: 10.1016/j.biomaterials.2013.01.075.PubMed",
    "Title": "Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus."
  },
  "3D Structure": []
}